FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) Short Interest Down 89.0% in August

FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) was the target of a large decrease in short interest during the month of August. As of August 31st, there was short interest totaling 3,417 shares, a decrease of 89.0% from the August 15th total of 30,976 shares. Based on an average trading volume of 7,563 shares, the days-to-cover ratio is currently 0.5 days. Approximately 0.0% of the company’s stock are sold short.

FT Vest U.S. Equity Deep Buffer ETF – October Price Performance

Shares of BATS DOCT traded down $0.09 during midday trading on Thursday, hitting $47.62. 4,983 shares of the company’s stock were exchanged, compared to its average volume of 11,033. The firm’s fifty day simple moving average is $47.24 and its 200-day simple moving average is $45.96. The company has a market cap of $391.91 million, a PE ratio of 24.90 and a beta of 0.37. FT Vest U.S. Equity Deep Buffer ETF – October has a twelve month low of $42.76 and a twelve month high of $48.42.

Institutional Trading of FT Vest U.S. Equity Deep Buffer ETF – October

A hedge fund recently raised its stake in FT Vest U.S. Equity Deep Buffer ETF – October stock. Winnow Wealth LLC grew its stake in FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) by 4,725.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 121,993 shares of the company’s stock after buying an additional 119,465 shares during the period. FT Vest U.S. Equity Deep Buffer ETF – October accounts for 4.1% of Winnow Wealth LLC’s investment portfolio, making the stock its 5th largest holding. Winnow Wealth LLC owned about 1.48% of FT Vest U.S. Equity Deep Buffer ETF – October worth $5,490,000 as of its most recent filing with the Securities and Exchange Commission.

FT Vest U.S. Equity Deep Buffer ETF – October Company Profile

The FT Cboe Vest U.S. Equity Deep Buffer ETF – October (DOCT) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPY over a specific holdings period. The actively-managed fund holds options and collateral. DOCT was launched on Oct 16, 2020 and is managed by First Trust.